creon 150 milligram capsules gastro-resistant
bgp products ltd - pancreas powder - capsules gastro-resistant - 150 milligram - enzyme preparations - multienzymes (amylase, lipase, protease) - pancreatic exocrine deficiency
creon 300 milligram capsules gastro-resistant
bgp products ltd - pancreas powder - capsules gastro-resistant - 300 milligram - enzyme preparations - multienzymes (amylase, lipase, protease) - for the treatment of pancreatic exocrine deficiency.
creon 400 milligram capsules gastro-resistant
bgp products ltd - pancreas powder - capsules gastro-resistant - 400 milligram - enzyme preparations - multienzymes (amylase, lipase, protease) - for the treatment of pancreatic exocrine insufficiency
creon for children 60.12 milligram granules gastro-resistant
bgp products ltd - pancreas powder - granules gastro-resistant - 60.12 milligram - enzyme preparations - multienzymes (amylase, lipase, protease) - for the treatment of pancreatic exocrine insufficiency
duphalac 3.335 g/5ml oral solution
bgp products ltd - lactulose - oral solution - 3.335 g/5ml - osmotically acting laxatives - osmotically acting laxatives - constipation hepatic encephalopathy (he): treatment and prevention of hepatic coma or precoma
duphaston 10 milligram film coated tablet
bgp products ltd - dydrogesterone - film coated tablet - 10 milligram - pregnadien derivatives - urinary system and sex hormones - in the management of conditions associated with progesterone insufficiency: dysmenorrhoea, endometriosis, infertility, irregular menstrual cycles and pre-menstrual syndrome. the drug may be used with an estrogen in the management of dysfunctional bleeding or secondary amenorrhoea, or in association with estrogen in hormone replacement therapy.
fematab 2 milligram film coated tablet
bgp products ltd - estradiol - film coated tablet - 2 milligram - natural and semisynthetic estrogens, plain - natural and semisynthetic oestrogens, plain - hormone replacement therapy (hrt) for oestrogen deficiency symptoms in postmenopausal women at least 6 months since last menses. prevention of osteoporosis in postmenopausal women at high risk of future fractures who are intolerant of, or contraindicated for, other medicinal products approved for the prevention of osteoporosis.
fematab 1 milligram film coated tablet
bgp products ltd - estradiol hemihydrate - film coated tablet - 1 milligram - natural and semisynthetic estrogens, plain - natural and semisynthetic oestrogens, plain - hormone replacement therapy (hrt) for oestrogen deficiency symptoms in postmenopausal women at least 6 months since last menses. prevention of osteoporosis in postmenopausal women at high risk of future fractures who are intolerant of, or contraindicated for, other medicinal products approved for the prevention of osteoporosis
femoston-conti 1mg/5mg milligram film coated tablet
bgp products ltd - estradiol, dydrogesterone - film coated tablet - 1mg/5mg milligram - progestogens and estrogens, fixed combinations - : genito urinary system and sex hormones, progestogens and oestrogens, fixed combinations - hormone replacement therapy (hrt) for oestrogen deficiency symptoms in postmenopausal women at least 12 months since last menses. prevention of osteoporosis in postmenopausal women at high risk of future fractures who are intolerant of, or contraindicated for, other medicinal products approved for the prevention of osteoporosis
isoptin 80mg film-coated tablets
bgp products ireland limited - verapamil hydrochloride - film-coated tablets - 80mg - selective calcium channel blockers with direct cardiac effects, phenylalkylamine - prophylaxis and/or treatment of:- angina pectoris, including prinzmetal’s angina (coronary spasm, vasospastic angina). supraventricular tachycardias such as paroxysmal supraventricular tachycardia, atrial fibrillation/flutter with rapid ventricular response (except in wpw syndrome, see “contraindications”). mild to moderate essential hypertension.